Search bioRxiv⌕ Search

bioRxiv · 10.1101/2021.06.02.446711

Evidence for the null hypothesis in functional magnetic resonance imaging using group-level Bayesian inference

Abstract

Classical null hypothesis significance testing is limited to the rejection of the point-null hypothesis; it does not allow the interpretation of non-significant results. Moreover, studies with a sufficiently large sample size will find statistically significant results even when the effect is negligible and may be considered practically equivalent to the null effect. This leads to a publication bias against the null hypothesis. There are two main approaches to assess null effects: shifting from the point-null to the interval-null hypothesis and considering the practical significance in the frequentist approach; using the Bayesian parameter inference based on posterior probabilities, or the Bayesian model inference based on Bayes factors. Herein, we discuss these statistical methods with particular focus on the application of the Bayesian parameter inference, as it is conceptually connected to both frequentist and Bayesian model inferences. Although Bayesian methods have been theoretically elaborated and implemented in commonly used neuroimaging software, they are not widely used for null effect assessment. To demonstrate the advantages of using the Bayesian parameter inference, we compared it with classical null hypothesis significance testing for fMRI data group analysis. We also consider the problem of choosing a threshold for a practically significant effect and discuss possible applications of Bayesian parameter inference in fMRI studies. We argue that Bayesian inference, which directly provides evidence for both the null and alternative hypotheses, may be more intuitive and convenient for practical use than frequentist inference, which only provides evidence against the null hypothesis. Moreover, it may indicate that the obtained data are not sufficient to make a confident inference. Because interim analysis is easy to perform using Bayesian inference, one can evaluate the data as the sample size increases and decide to terminate the experiment if the obtained data are sufficient to make a confident inference. To facilitate the application of the Bayesian parameter inference to null effect assessment, scripts with a simple GUI were developed.

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Masharipov, R., Nikolaev, Y., Korotkov, A., Didur, M., Cherednichenko, D., Kireev, M.. 2021-06-02. Evidence for the null hypothesis in functional magnetic resonance imaging using group-level Bayesian inference. https://doi.org/10.1101/2021.06.02.446711

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Rab10 and Arhgef7 interact to promote axon extension by linking vesicle supply and exocytosis

The formation of functional neural circuits begins with the extension of a single axon by immature neurons. Axon elongation requires an expansion of the plasma membrane that depends on the polarization of vesicle trafficking and exocytosis. It is not completely understood how the increased transport of vesicles into the growing axon is linked to their subsequent insertion into the plasma membrane. An analysis of early stages of neuronal differentiation indicates that an asymmetry in neurite length precedes axon specification and the accumulation of PPVs in the nascent axon. We show that increasing the transport of vesicles in unpolarized neurons is sufficient to promote the extension of additional axons. This effect indicates that an increased supply of vesicles stimulates their subsequent insertion into the membrane to allow neurite growth. The link between vesicle transport and exocytosis is mediated by the interaction of Rab10 with Arhgef7. Rab10 stimulates Arhgef7 activity on PPVs as a GEF for Cdc42b to promote axon extension through exocyst-dependent exocytosis, suggesting that their interaction links the increased supply of PPVs to their exocytosis.

neuroscience↗

Subcellular Spatial Profiling Unveils Links Between Neuritic Plaques with Selective Tau Vulnerability in Alzheimer's Disease

Alzheimer's disease (AD) features widespread extracellular amyloid-{beta} plaques but selective intraneuronal tau accumulation in cortical layers II/III and V, while layer IV remains relatively resistant. Here, we combined subcellular spatial transcriptomics with co-registered A{beta} and pTau immunohistochemistry to determine why neurons exposed to comparable plaque-associated pathology differ in somatic pTau accumulation. Plaque-associated neuritic stress occurred similarly across layers, but layer IV neurons showed attenuated pTau accumulation and reduced somatic expression of a shared neurite-soma stress program involving DCTN1, CALM3, NORAD, and PIN1. Trajectory analysis within layers identified tau-vulnerable and resistant neuronal states implicating calcium signaling, retrograde transport, and lysosomal function. Notably, astrocytic APOE-neuronal LRP1 co-expression increased significantly along the pTau-vulnerable trajectory, and APOE {epsilon}4 was associated with stronger coupling of local plaque pathology to pTau-associated molecular programs. These findings reveal neuronal programs and neuron-glia interactions underlying selective tau vulnerability and resistance in AD, highlighting potential tau-targeting therapeutics.

neuroscience↗

Widespread oscillatory suppression in autism persists in the absence of psychotropic medication.

Purpose: Investigate the neural oscillatory activity associated with autism spectrum disorder (ASD) using electroencephalographic (EEG) recordings in children and adolescents. Compare the corresponding oscillatory power between ASD patients taking psychotropic medication with a drug-naive group. Methods: ASD diagnosis was done using DSM-IV and CARS (Childhood Autism Rating Scale). EEG recordings employed 22 scalp electrodes (10/20 system). ASD vs. neurotypical groups were matched for sex and age (5 females; average age: ~10 years old). We analyzed the resting state (eyes open) EEG power spectrum during ~2-minute recordings. The multitaper FFT method was used to estimate spectral power for the delta, theta, alpha, beta and gamma frequency bands. We pooled together data from several electrodes to compute comprehensive power spectra and assess the oscillatory behavior of macro brain regions. Results: We observed widespread (~4Hz - 20Hz) oscillatory suppression comprising the theta, alpha and beta frequency bands. The most widespread and robust ASD-associated power suppression was in the high theta and alpha bands. Delta and gamma bands showed no significant power change for any of the brain regions studied. Results from a subgroup of patients (N = 9) who never used psychotropics confirmed these findings, indicating that they are not an artifact of medication. Conclusion: Suppression in theta, alpha and beta oscillations may offer insights into the neurophysiological underpinnings of autism and could be used as an accessible and comprehensive tool in ASD diagnosis, regardless of the patients being or not on medication.

neuroscience↗